Jan 14 (Reuters) - British cell and gene therapy manufacturer Oxford Biomedica confirmed on Wednesday that it has received an unsolicited cash offer from funds managed by EQT for all of its shares. (
Oxford Biomedica Acknowledges Unsolicited Cash Offer from EQT Funds
Oxford Biomedica's Unsolicited Offer
Jan 14 (Reuters) - British cell and gene therapy manufacturer Oxford Biomedica confirmed on Wednesday that it has received an unsolicited cash offer from funds managed by EQT for all of its shares.
Details of the Offer
(Reporting by Unnamalai L in Bengaluru; Editing by Alan Barona)


